ArticleJournal of neuroinflammation2024

Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy.

Devin Wahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.